+ All Categories
Home > Documents > PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance...

PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance...

Date post: 27-Jul-2020
Category:
Upload: others
View: 19 times
Download: 0 times
Share this document with a friend
46
PHARMACOVIGILANCE OF PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF DRUGS OF INDIAN SYSTEM OF MEDICINE MEDICINE Do we need evidence for • Efficacy Safety Safety
Transcript
Page 1: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

PHARMACOVIGILANCE OF PHARMACOVIGILANCE OF

DRUGS OF INDIAN SYSTEM OF DRUGS OF INDIAN SYSTEM OF

MEDICINEMEDICINE

Do we need evidence for

• Efficacy

• Safety• Safety

Page 2: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Prof. K. C. SinghalProf. K. C. SinghalProf. K. C. SinghalProf. K. C. SinghalM.D., Ph.D. (Medicine), D.Sc., F.I.A.N., F.I.P.S., F.I.A.M.S.

Consultant WHO Center for International Drug Monitoring, Uppsala, Sweden

Vice Vice Vice Vice ---- Chancellor,Chancellor,Chancellor,Chancellor,

NIMS UniversityNIMS UniversityNIMS UniversityNIMS University

JaipurJaipurJaipurJaipur

Page 3: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

rns~orns~orns~orns~orns~orns~orns~orns~o ;;;;;;;;qDraqDraqDraqDraqDraqDraqDraqDra HkS"kT;aHkS"kT;aHkS"kT;aHkS"kT;aHkS"kT;aHkS"kT;aHkS"kT;aHkS"kT;a ;;;;;;;;n~kjksX;kn~kjksX;kn~kjksX;kn~kjksX;kn~kjksX;kn~kjksX;kn~kjksX;kn~kjksX;k; ; ; ; ; ; ; ; dYirsAdYirsAdYirsAdYirsAdYirsAdYirsAdYirsAdYirsA l l l l l l l l pSopSopSopSopSopSopSopSo

fHk"ktkafHk"ktkafHk"ktkafHk"ktkafHk"ktkafHk"ktkafHk"ktkafHk"ktka Js"BksJs"BksJs"BksJs"BksJs"BksJs"BksJs"BksJs"Bks jksxsH;ksjksxsH;ksjksxsH;ksjksxsH;ksjksxsH;ksjksxsH;ksjksxsH;ksjksxsH;ks ;% ;% ;% ;% ;% ;% ;% ;% izeksp;srizeksp;srizeksp;srizeksp;srizeksp;srizeksp;srizeksp;srizeksp;sr~ AA~ AA~ AA~ AA~ AA~ AA~ AA~ AA

C.A.1 Sutrasthana 1.134

To produce its characteristic effects a drug must be

administered in proper dosage form by proper route and must

be present in appropriate concentration at the site of action.

many variables that effect transport across membranes many variables that effect transport across membranes

influence absorption of drugs . Time of administration of drug

i.e with relation to stomach being empty or otherwise, during

day or at night and other factors may influence absorption.

This is amply emphasized in Ayurveda that very medicine may

be taken as properly administered which is capable to bring

about disease free condition and that very physician as the

best one who could relieve (the patient) of his disorder.

Page 4: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

;;;;;;;;FkkFkkFkkFkkFkkFkkFkkFkk fo"ka;Fkkfo"ka;Fkkfo"ka;Fkkfo"ka;Fkkfo"ka;Fkkfo"ka;Fkkfo"ka;Fkkfo"ka;Fkk ''''''''kLkLkLkLkLkLkLkL=ka ;=ka ;=ka ;=ka ;=ka ;=ka ;=ka ;=ka ;Fkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkAFkk·fuj'kfu;ZFkkArFkkS"krFkkS"krFkkS"krFkkS"krFkkS"krFkkS"krFkkS"krFkkS"k////////kefoKkrakefoKkrakefoKkrakefoKkrakefoKkrakefoKkrakefoKkrakefoKkra foKkre`rafoKkre`rafoKkre`rafoKkre`rafoKkre`rafoKkre`rafoKkre`rafoKkre`ra ;;;;;;;;FkkFkkFkkFkkFkkFkkFkkFkk AAAAAAAAAAAAAAAA

vkS"k|avkS"k|avkS"k|avkS"k|avkS"k|avkS"k|avkS"k|avkS"k|a áufHkKkraáufHkKkraáufHkKkraáufHkKkraáufHkKkraáufHkKkraáufHkKkraáufHkKkra uke:ixq.kSfLuke:ixq.kSfLuke:ixq.kSfLuke:ixq.kSfLuke:ixq.kSfLuke:ixq.kSfLuke:ixq.kSfLuke:ixq.kSfL========kfHk%AkfHk%AkfHk%AkfHk%AkfHk%AkfHk%AkfHk%AkfHk%A foKkrafoKkrafoKkrafoKkrafoKkrafoKkrafoKkrafoKkra pkfipkfipkfipkfipkfipkfipkfipkfinq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rsnq;qZDreuFkkZ;ksii|rs AAAAAAAAAAAAAAAA

C.A.1 Sutrasthana 1. 124-125

A drug, if unknown, is (fatal) like poison, weapon, fire and thunderbolt while, if known is weapon, fire and thunderbolt while, if known is (vitaliser) like nector. A drug unknown by these -name, form and properties (including actions) - and badly administered even if known are responsible for complications. Drawing attention to causation of adverse reactions by drugs and their treatment, Charak states that in case there appear thirst, mental confusion, giddiness and fainting during digestion of the drug, pitta - alleviating, sweet and cold measures are recommended.

Page 5: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

nw"khfo"kanw"khfo"ka rqrq

''kksf.krnq"V;kkksf.krnq"V;k#%#%fdfVHkdksBfyaM~xfdfVHkdksBfyaM~x pApA

fo"kesdSdafo"kesdSda nks"kanks"ka lanwlanw"; "; gjR;lwusoegjR;lwusoe~ ~

AAAA

C.A.2 Chikitsasthanam .23.31

Dusivisa (latent poison) produces pustules, Dusivisa (latent poison) produces pustules,

kitibha and urticarial rashes due to

disorders of blood. Thus poison takes away

life soon by affecting each dosa.

Page 6: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Traditional Medicine is the sum total of knowledge, Traditional Medicine is the sum total of knowledge, Traditional Medicine is the sum total of knowledge, Traditional Medicine is the sum total of knowledge,

skills and practices based on the theories, beliefs skills and practices based on the theories, beliefs skills and practices based on the theories, beliefs skills and practices based on the theories, beliefs

and experiences indigenous to different cultures, and experiences indigenous to different cultures, and experiences indigenous to different cultures, and experiences indigenous to different cultures,

whether explicable or not, used in the maintenance whether explicable or not, used in the maintenance whether explicable or not, used in the maintenance whether explicable or not, used in the maintenance

of health as well as in prevention, diagnosis, of health as well as in prevention, diagnosis, of health as well as in prevention, diagnosis, of health as well as in prevention, diagnosis,

skills and practices based on the theories, beliefs skills and practices based on the theories, beliefs skills and practices based on the theories, beliefs skills and practices based on the theories, beliefs

and experiences indigenous to different cultures, and experiences indigenous to different cultures, and experiences indigenous to different cultures, and experiences indigenous to different cultures,

whether explicable or not, used in the maintenance whether explicable or not, used in the maintenance whether explicable or not, used in the maintenance whether explicable or not, used in the maintenance

of health as well as in prevention, diagnosis, of health as well as in prevention, diagnosis, of health as well as in prevention, diagnosis, of health as well as in prevention, diagnosis,

improvement or treatment of physical and mental improvement or treatment of physical and mental improvement or treatment of physical and mental improvement or treatment of physical and mental

illness.illness.illness.illness.

Page 7: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

♦♦♦♦ Medicinal Plants for Primary Care

♦♦♦♦ 65 to 80% world population use traditional Medicine

♦♦♦♦ Use based on historical and anecdotal evidence

♦♦♦♦ Little data with regard to efficacy

Page 8: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Pharmacovigilance in Traditional Medicine

Galen

"If you need a single drug of good quality which is not available, use a drug of lesser quality, for it would be less harmful then if you want to prepare a compound drug of which one single drug is unavailable, use the lesser quality drug double the weight of the original drug. Thus the efficacy of the drug would remain drug. Thus the efficacy of the drug would remain unchanged."

Page 9: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Maqala Fi Abdal Al-Adwiya Al Mustamala Fi

Al-Tib wa Al-Ilaj (Kitab Al-Abdal)

" All the drugs required for the treatment are

not available everywhere. So, if the physician not available everywhere. So, if the physician

is unaware of substitutes which may be used

in place of the original drug, the objectivity

and benefaction of this medical profession

would cease".

Page 10: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Examples of compound drugs along with substitutes

Drug Substitute

Dawa al-Qust Dawa ul-Kurkum

Dawa al-Luk

Roghan-e-hina Roghan-e-Marzanjosh

Roghan-e-gul Roghan-e-Banafsha

Page 11: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Principles of substitutionsAvicenna - Substitute should only be used when

original drug meant to be used is not available.

Avicenna - No drug can be a complete substitute for another drug in all respects.

Rhazes - Drug should be substituted for original drug for specific activity

- Different drugs may be substituted for different action

- Substituted drug should match the original in mijaz (Temperament)

Page 12: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Pharmacovigilance !

12-11-2014 12

C. S., Su.- 1:124

All drugs are dangerous some may also be useful

N Moore, BMJ,2005,330, 539-40

Page 13: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

What is Pharmacovigilance !

C. S., Su.- 1:124

"No drug which is pharmacologically effective is entirely

Wednesday, 12 November 2014 13

All drugs are dangerous some may also be usefulMoore, BMJ,2005,330, 539-40

"No drug which is pharmacologically effective is entirely without hazard. The hazard may be insignificant or may be acceptable in relation to the drug's therapeutic action. Furthermore, not all hazards can be known before a drug is marketed... “A report by EU experts”

Page 14: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

No medicinal product is entirely or absolutely safe for all people, in all places, at all times. We must always live with some measure of uncertainty.

Wednesday, 12 November 2014

14

Page 15: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

� Medicinal Plants for Primary Care

� 65 to 80% world population use safety traditional Medicine

� Use based on historical and anccdotal evidence

� Little data with regard to efficacy

Page 16: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Pharmacovigilance

• Any thing herbal is safe!!?????

• Adverse drug reactions (ADR)

• Drug-drug interactions• Drug-drug interactions

• Herb-Drug interactions

• Toxicity of the isolated ingredients

• Traditional process (Shodhana)

Page 17: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

IndiaIndiaIndiaIndia

Herbal DrugsHerbal DrugsHerbal DrugsHerbal Drugs

Widely PrescribedWidely PrescribedWidely PrescribedWidely PrescribedWidely PrescribedWidely PrescribedWidely PrescribedWidely Prescribed

Lack of Systematic EvaluationLack of Systematic EvaluationLack of Systematic EvaluationLack of Systematic Evaluation

Adverse Drug ReactionsAdverse Drug ReactionsAdverse Drug ReactionsAdverse Drug Reactions

Page 18: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Traditional MedicineTraditional MedicineTraditional MedicineTraditional Medicine

Why ADR Monitoring DifficultWhy ADR Monitoring DifficultWhy ADR Monitoring DifficultWhy ADR Monitoring Difficult

♦ Theories of application are difficult

♦ Too many products to monitor

♦ Multiple ingredient formulations -numerousnumerous

♦ Herbal and allopathic drugs taken together

♦ Formulations change keeping same brand name

♦ Methods of preparations differ

♦ Quality checking is ambiguous

Page 19: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Health care system in India

• Allopathy – Disease oriented

• Ayurveda - (Holistic system)

• Unani - (Holistic system)

• Siddha - (Holistic system)• Siddha - (Holistic system)

• Homeopathy Symptom based

• Conference

Page 20: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Principles of Treatment are different

• Ayurveda - VATA

• - Pitta

• - Kafa

Page 21: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

MijazMijazMijazMijaz (Temperament) (Temperament) (Temperament) (Temperament)

Drug could be

Hot + Dry

Hot + Moist

Cold + Dry

Cold + MoistCold + Moist

•••• Hot, Cold, Dry, Moist - each has degrees from 1-3

• • • • A drug hot and dry in 1st degree be substituted with hot and dry 1st degree

Page 22: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Why is ADR monitoring of ‘Herbal’ drugs even more

difficult?

Too many products

to monitor?to monitor?

Page 23: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Why is ADR monitoring of

‘Herbal’ drugs even more

difficult?

There are single and multiple ingredient formulations

Page 24: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

The formulations can be changed at will keeping the

same brand name

Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of ‘Herbal’ drugs even more difficult?‘Herbal’ drugs even more difficult?‘Herbal’ drugs even more difficult?‘Herbal’ drugs even more difficult?

same brand name

Page 25: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Quality checking is ambiguous affecting the

causality of an ADR

Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of ‘Herbal’ drugs even more ‘Herbal’ drugs even more ‘Herbal’ drugs even more ‘Herbal’ drugs even more

difficult?difficult?difficult?difficult?

causality of an ADR

Page 26: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Herbal products are taken OTC by patients

Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of ‘Herbal’ drugs even more ‘Herbal’ drugs even more ‘Herbal’ drugs even more ‘Herbal’ drugs even more

difficult?difficult?difficult?difficult?

Page 27: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Herbal products are prescribed by Herbal products are prescribed by Herbal products are prescribed by Herbal products are prescribed by all specialities i.e. Allopaths, all specialities i.e. Allopaths, all specialities i.e. Allopaths, all specialities i.e. Allopaths,

Ayurveds, Homeopaths and RMPsAyurveds, Homeopaths and RMPsAyurveds, Homeopaths and RMPsAyurveds, Homeopaths and RMPs

Why is ADR monitoring of ‘Herbal’ drugs even more

difficult?

Ayurveds, Homeopaths and RMPsAyurveds, Homeopaths and RMPsAyurveds, Homeopaths and RMPsAyurveds, Homeopaths and RMPs

Page 28: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

The ADR reporting terminology of The ADR reporting terminology of The ADR reporting terminology of The ADR reporting terminology of

multiple specialties can differmultiple specialties can differmultiple specialties can differmultiple specialties can differ

Why is ADR monitoring of ‘Herbal’ drugs even more

difficult?

Page 29: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Herbal and Allopathic drugs are Herbal and Allopathic drugs are Herbal and Allopathic drugs are Herbal and Allopathic drugs are taken together by the same taken together by the same taken together by the same taken together by the same

Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of Why is ADR monitoring of ‘Herbal’ drugs even more ‘Herbal’ drugs even more ‘Herbal’ drugs even more ‘Herbal’ drugs even more

difficult?difficult?difficult?difficult?

taken together by the same taken together by the same taken together by the same taken together by the same patientpatientpatientpatient

Page 30: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Substitution of DrugsSubstitution of DrugsSubstitution of DrugsSubstitution of Drugs

12-11-2014 30

Page 31: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

IPGT&RA

JAMNAGAR

N

BHU

National PV centre

8 Regional PV centres

S

THIRUVAN

E

GUWHATI

Substitution of DrugsSubstitution of DrugsSubstitution of DrugsSubstitution of Drugs

BHU

W

NIAS

30 Peripheral PV centres

THIRUVAN

TAPURAM

CCRAS

NEWDELHI

SIDDHA

CHENNAI

UNANI

BANGALORE

C

BHOPAL

National Pharmacovigilance Programme For ASU Drugs

Page 32: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Ibn SinaThe Author of Al Qanoon Fil Tibb (Canon of

Medicine)

Page 33: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Abu Abu Abu Abu BakrBakrBakrBakr Mohammad bin Mohammad bin Mohammad bin Mohammad bin ZakariyyaZakariyyaZakariyyaZakariyya al al al al RaziRaziRaziRazi((((RhazesRhazesRhazesRhazes))))

•••• Born in Iran 240 Born in Iran 240 Born in Iran 240 Born in Iran 240 Born in Iran 240 Born in Iran 240 Born in Iran 240 Born in Iran 240 hijrihijrihijrihijrihijrihijrihijrihijri

· Studied Indian Medicine· Studied Indian Medicine· Studied Indian Medicine· Studied Indian Medicine· Studied Indian Medicine· Studied Indian Medicine· Studied Indian Medicine· Studied Indian Medicine

· Chief Medical Officer in hospital of · Chief Medical Officer in hospital of · Chief Medical Officer in hospital of · Chief Medical Officer in hospital of · Chief Medical Officer in hospital of · Chief Medical Officer in hospital of · Chief Medical Officer in hospital of · Chief Medical Officer in hospital of BaghdadBaghdadBaghdadBaghdadBaghdadBaghdadBaghdadBaghdad

· · · · · · · · Became blind at 60Became blind at 60Became blind at 60Became blind at 60Became blind at 60Became blind at 60Became blind at 60Became blind at 60

· 29 books written by · 29 books written by · 29 books written by · 29 books written by · 29 books written by · 29 books written by · 29 books written by · 29 books written by RhazesRhazesRhazesRhazesRhazesRhazesRhazesRhazes are availableare availableare availableare availableare availableare availableare availableare available

Page 34: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,
Page 35: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

MaqalaMaqalaMaqalaMaqala FiFiFiFi AbdalAbdalAbdalAbdal AlAlAlAl----AdwiyaAdwiyaAdwiyaAdwiya Al Al Al Al MustamalaMustamalaMustamalaMustamalaFiAlFiAlFiAlFiAl----TibTibTibTib wawawawa AlAlAlAl----IlajIlajIlajIlaj ((((KitabKitabKitabKitab AlAlAlAl----AbdalAbdalAbdalAbdal))))

"All the drugs required for the "All the drugs required for the "All the drugs required for the "All the drugs required for the treatment are not available every treatment are not available every treatment are not available every treatment are not available every where. So, if the physician is unaware where. So, if the physician is unaware where. So, if the physician is unaware where. So, if the physician is unaware of substitutes which may be used in of substitutes which may be used in of substitutes which may be used in of substitutes which may be used in of substitutes which may be used in of substitutes which may be used in of substitutes which may be used in of substitutes which may be used in place of the original drug, the place of the original drug, the place of the original drug, the place of the original drug, the objectivity and benefaction of this objectivity and benefaction of this objectivity and benefaction of this objectivity and benefaction of this medical profession would cease".medical profession would cease".medical profession would cease".medical profession would cease".

Page 36: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Examples of compound drugs along with Examples of compound drugs along with Examples of compound drugs along with Examples of compound drugs along with substitutessubstitutessubstitutessubstitutes

Drug Substitute

Dawa al-Qust Dawa ul-Kurkum

Dawa al-LukDawa al-Luk

Roghan-e-hina Roghan-e-Marzanjosh

Roghan-e-gul Roghan-Banafsha

Page 37: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Principles of Principles of Principles of Principles of

substitutionssubstitutionssubstitutionssubstitutionsAvicenna - Substitute should only be used

when original drug meant to be used is not available.

Avicenna - No drug can be a complete substitute for another drug in all respects.respects.

Rhazes - Drug should be substituted for original drug for specific activity

- Different drugs may be substituted for different action

- Substituted drug should match the original in mijaz (Temperament)

Page 38: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Substitution (Substitution (Substitution (Substitution (AbdalAbdalAbdalAbdal alalalal----adviyaadviyaadviyaadviya) Drug of one origin ) Drug of one origin ) Drug of one origin ) Drug of one origin can be replaced with drug of another origin.can be replaced with drug of another origin.can be replaced with drug of another origin.can be replaced with drug of another origin.

Example :

Drug Substitute

Jund Bedastar (Animal) Black pepper (1/2 by weight) (Plant)

Calcinated & washed egg Tarasis (Gummiferum)

shell

One species of plant may substitute for another species

Podina kohi (Mentha) Podina Nahri (Panny Royal)

Another part of same plant may serve as substitute

Margosa flower Margosa leave or bark

Sosan leaves (Lilly) Sosan Root

Banafsha

Page 39: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Substitution of Drugs in Ayurveda

• Not mentioned in Charak and sushruta samhita

• According to three Nighantus (Materia Medica)

• Bhavprakash

• Yogaratnakar• Yogaratnakar

• Bhashjya Ratnavali

Page 40: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

• RASA Physical Properties

• GUNA Pharmacological actions

If any drug is not available then another drug similar can be substituted

Substitution of Drugs in Ayurveda

• GUNA Pharmacological actions

• VIRYA Potency

• VIPAKA Effect on digestion and interaction

Page 41: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

• Main drug in any formulation should not be substituted .

• Other drugs can be substituted

Substitution of Drugs in Ayurveda

• Other drugs can be substituted appropriately (Pratinidhi Dravya)

Page 42: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Mile Stones for the launch of National Mile Stones for the launch of National Mile Stones for the launch of National Mile Stones for the launch of National Mile Stones for the launch of National Mile Stones for the launch of National Mile Stones for the launch of National Mile Stones for the launch of National Pharmacovigilance Pharmacovigilance Pharmacovigilance Pharmacovigilance Pharmacovigilance Pharmacovigilance Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammeProgrammeProgrammeProgrammeProgrammeProgramme for ASU for ASU for ASU for ASU for ASU for ASU for ASU for ASU

Drugs:Drugs:Drugs:Drugs:Drugs:Drugs:Drugs:Drugs:

Consultative Committee meeting :Consultative Committee meeting :Consultative Committee meeting :Consultative Committee meeting :

at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi at AYUSH, New Delhi

2929292929292929thththththththth & 30& 30& 30& 30& 30& 30& 30& 30thththththththth of August 08 of August 08 of August 08 of August 08 of August 08 of August 08 of August 08 of August 08

under the sponsorship of under the sponsorship of under the sponsorship of under the sponsorship of under the sponsorship of under the sponsorship of under the sponsorship of under the sponsorship of

WHO, India Office WHO, India Office WHO, India Office WHO, India Office WHO, India Office WHO, India Office WHO, India Office WHO, India Office

Protocol was finalized.Protocol was finalized.Protocol was finalized.Protocol was finalized.

Page 43: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

11/12/2014

Page 44: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

11/12/2014

Page 45: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,
Page 46: PHARMACOVIGILANCE OF DRUGS OF INDIAN SYSTEM OF … · Pharmacovigilance Pharmacovigilance ProgrammeProgrammeProgrammefor ASU for ASU Drugs: Consultative Committee meeting : at AYUSH,

Recommended